These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23275028)

  • 21. The development and biology of bradyzoites of Toxoplasma gondii.
    Weiss LM; Kim K
    Front Biosci; 2000 Apr; 5():D391-405. PubMed ID: 10762601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding mechanisms and the role of differentiation in pathogenesis of Toxoplasma gondii: a review.
    Sullivan WJ; Smith AT; Joyce BR
    Mem Inst Oswaldo Cruz; 2009 Mar; 104(2):155-61. PubMed ID: 19430637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-time RT-PCR on SAG1 and BAG1 gene expression during stage conversion in immunosuppressed mice infected with Toxoplasma gondii Tehran strain.
    Selseleh M; Modarressi MH; Mohebali M; Shojaee S; Eshragian MR; Selseleh M; Azizi E; Keshavarz H
    Korean J Parasitol; 2012 Sep; 50(3):199-205. PubMed ID: 22949746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stress-related and spontaneous stage differentiation of Toxoplasma gondii.
    Ferreira da Silva Mda F; Barbosa HS; Gross U; Lüder CG
    Mol Biosyst; 2008 Aug; 4(8):824-34. PubMed ID: 18633484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of a Toxoplasma gondii chromatin remodeling complex ortholog in developmental regulation.
    Rooney PJ; Neal LM; Knoll LJ
    PLoS One; 2011; 6(5):e19570. PubMed ID: 21655329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of an in vitro system to study the developmental stages of Toxoplasma gondii using a genetically modified strain expressing markers for tachyzoites and bradyzoites.
    Portes JA; De Souza W
    Parasitol Res; 2019 Dec; 118(12):3479-3489. PubMed ID: 31728720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxoplasma gondii: determinants of tachyzoite to bradyzoite conversion.
    Skariah S; McIntyre MK; Mordue DG
    Parasitol Res; 2010 Jul; 107(2):253-60. PubMed ID: 20514494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxoplasma gondii Hsp90 is a potential drug target whose expression and subcellular localization are developmentally regulated.
    Echeverria PC; Matrajt M; Harb OS; Zappia MP; Costas MA; Roos DS; Dubremetz JF; Angel SO
    J Mol Biol; 2005 Jul; 350(4):723-34. PubMed ID: 15967463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stage-specific expression of a selectable marker in Toxoplasma gondii permits selective inhibition of either tachyzoites or bradyzoites.
    Bohne W; Roos DS
    Mol Biochem Parasitol; 1997 Sep; 88(1-2):115-26. PubMed ID: 9274873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lactate dehydrogenase in Toxoplasma gondii controls virulence, bradyzoite differentiation, and chronic infection.
    Abdelbaset AE; Fox BA; Karram MH; Abd Ellah MR; Bzik DJ; Igarashi M
    PLoS One; 2017; 12(3):e0173745. PubMed ID: 28323833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted disruption of the bradyzoite-specific gene BAG1 does not prevent tissue cyst formation in Toxoplasma gondii.
    Bohne W; Hunter CA; White MW; Ferguson DJ; Gross U; Roos DS
    Mol Biochem Parasitol; 1998 May; 92(2):291-301. PubMed ID: 9657333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction and validation of a polycompetitor construct (SWITCH) for use in competitive RT-PCR to assess tachyzoite-bradyzoite interconversion in Toxoplasma gondii.
    Lyons RE; Lyons K; McLeod R; Roberts CW
    Parasitology; 2001 Nov; 123(Pt 5):433-9. PubMed ID: 11719953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclic nucleotide kinases and tachyzoite-bradyzoite transition in Toxoplasma gondii.
    Eaton MS; Weiss LM; Kim K
    Int J Parasitol; 2006 Jan; 36(1):107-14. PubMed ID: 16216248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of dual fluorescent stage specific reporter strain of Toxoplasma gondii to follow tachyzoite and bradyzoite development in vitro and in vivo.
    Paredes-Santos TC; Tomita T; Yan Fen M; de Souza W; Attias M; Vommaro RC; Weiss LM
    Microbes Infect; 2016 Jan; 18(1):39-47. PubMed ID: 26432517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A change in the premitotic period of the cell cycle is associated with bradyzoite differentiation in Toxoplasma gondii.
    Radke JR; Guerini MN; Jerome M; White MW
    Mol Biochem Parasitol; 2003 Oct; 131(2):119-27. PubMed ID: 14511810
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Huang S; Holmes MJ; Radke JB; Hong DP; Liu TK; White MW; Sullivan WJ
    mSphere; 2017; 2(2):. PubMed ID: 28317026
    [No Abstract]   [Full Text] [Related]  

  • 37. Dynamics of Toxoplasma gondii differentiation.
    Dzierszinski F; Nishi M; Ouko L; Roos DS
    Eukaryot Cell; 2004 Aug; 3(4):992-1003. PubMed ID: 15302832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative studies of Toxoplasma gondii transcriptomes: insights into stage conversion based on gene expression profiling and alternative splicing.
    Chen LF; Han XL; Li FX; Yao YY; Fang JP; Liu XJ; Li XC; Wu K; Liu M; Chen XG
    Parasit Vectors; 2018 Jul; 11(1):402. PubMed ID: 29996885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a Master Regulator of Differentiation in Toxoplasma.
    Waldman BS; Schwarz D; Wadsworth MH; Saeij JP; Shalek AK; Lourido S
    Cell; 2020 Jan; 180(2):359-372.e16. PubMed ID: 31955846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The GRA17 Parasitophorous Vacuole Membrane Permeability Pore Contributes to Bradyzoite Viability.
    Paredes-Santos T; Wang Y; Waldman B; Lourido S; Saeij JP
    Front Cell Infect Microbiol; 2019; 9():321. PubMed ID: 31572690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.